Pegasta 6mg Injection By Oncotrust

Fegasta Injection contains Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (Peg-G-CSF) 6 mg, used to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing chemotherapy. It helps stimulate the production of neutrophils, thereby strengthening the immune system and reducing the risk of infections.
Key Benefits:
Promotes rapid recovery of neutrophil count
Reduces infection risk during cancer chemotherapy
Long-acting formulation once-per-cycle dosing
Improves patient compliance and treatment outcomes
Composition:
Pegylated Recombinant Human Granulocyte Colony Stimulating Factor 6 mg
Indications:
Chemotherapy-induced neutropenia
Prevention of febrile neutropenia in cancer patients
Dosage & Administration:
Administered as a subcutaneous injection
Dosage as prescribed by the treating physician
Storage Instructions:
Store at 2C to 8C (Refrigerated)
Do not freeze
Protect from light
Packaging:
Pre-filled syringe / vial (as per availability)
Safety Information:
For prescription use only
To be used under medical supervision
Not recommended for self-medication